(Q37983019)

26 August 2017

title

Lamotrigine in the treatment of unipolar depression with and without comorbidities: a literature review (English)

1 reference

26 August 2017

1 reference

1 reference

1 reference

1 reference

Adam Daniel Zavodnick

series ordinal

1

1 reference

26 August 2017

Rizwan Ali

series ordinal

2

1 reference

26 August 2017

publication date

1 September 2012

1 reference

26 August 2017

published in

Psychiatric Quarterly

1 reference

26 August 2017

volume

83

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

371-383

1 reference

https://scigraph.springernature.com/pub.10.1007/s11126-012-9208-4

26 August 2017

exact match

0 references

cites work

Potential Mechanisms of Action of Lamotrigine in the Treatment of Bipolar Disorders

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

Lamotrigine augmentation in unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

Lamotrigine adjunctive treatment in resistant unipolar depression: an open, descriptive study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

Efficacy and safety of antidepressant augmentation with lamotrigine in patients with treatment-resistant depression: a randomized, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

Lamotrigine administration in panic disorder with agoraphobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

Lamotrigine treatment of aggression in female borderline patients, Part II: an 18-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

Lamotrigine: a review of its use in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

Diagnosis and definition of treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-012-9208-4

Lamotrigine as an augmentation agent in treatment-resistant depression

21 January 2018

1 reference

12 December 2020

Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium.

1 reference

12 December 2020

Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder

1 reference

12 December 2020

Persistent attentional dysfunction in remitted bipolar disorder

1 reference

12 December 2020

A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder.

1 reference

12 December 2020

A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

1 reference

12 December 2020

A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes

1 reference

12 December 2020

When at first you don't succeed: sequential strategies for antidepressant nonresponders

1 reference

12 December 2020

Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study

1 reference

12 December 2020

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

1 reference

12 December 2020

Lamotrigine augmentation strategy for patients with treatment-resistant depression

1 reference

12 December 2020

Adjunctive lamotrigine treatment for major depression

1 reference

12 December 2020

Lamotrigine add-on therapy in focal epilepsy: electroencephalographic and neuropsychological evaluation.

1 reference

12 December 2020

Outcomes of add-on treatment with lamotrigine in partial epilepsy

1 reference

12 December 2020

10.1007/S11126-012-9208-4

Identifiers

DOI

1 reference

26 August 2017

1 reference